New Weight Loss Medications Available in Australia (2026)

by Burst Health April 8, 2026

The landscape of prescription weight management in Australia is changing. Over the past several years, new classes of medication have entered the regulatory pipeline, and the Therapeutic Goods Administration (TGA) continues to evaluate treatments that may offer additional options for Australians living with obesity or overweight. For patients and prescribers alike, understanding what is happening in this space — and what it means in practical terms — is increasingly important.

It is worth stating clearly from the outset: the availability of new medications does not change the fundamentals of weight management care in Australia. Every prescription weight loss medication requires a medical assessment, a valid prescription from an authorised prescriber, and ongoing clinical monitoring. "New" does not mean universally suitable, and no medication replaces the need for individualised medical advice. This article is intended as general health information only and should not be taken as medical advice or a recommendation for any specific treatment.

How New Medications Are Approved in Australia

Before any prescription medication can be legally supplied in Australia, it must be evaluated and registered by the Therapeutic Goods Administration (TGA). The TGA is an independent statutory authority within the Department of Health and Aged Care, and its role is to assess the quality, safety, and efficacy of therapeutic goods based on scientific and clinical evidence.

The approval process typically follows these stages:

Sponsor application — A pharmaceutical company (the "sponsor") submits a formal application to the TGA, including clinical trial data, manufacturing information, and proposed product labelling.
TGA evaluation — The TGA conducts a thorough scientific evaluation of the submitted evidence. For prescription medicines, this is usually done through the registration process under Section 25 of the Therapeutic Goods Act 1989.
Advisory committee review — In many cases, applications are also reviewed by advisory committees such as the Advisory Committee on Medicines (ACM), which provide independent expert advice to the TGA.
Registration on the ARTG — If the TGA is satisfied that the medicine meets acceptable standards of quality, safety, and efficacy, it is entered on the Australian Register of Therapeutic Goods (ARTG). Only products listed or registered on the ARTG can be lawfully supplied in Australia.
PBS consideration (separate process) — After TGA registration, the sponsor may apply to have the medicine listed on the Pharmaceutical Benefits Scheme (PBS), which would make it available at a subsidised cost. This is a separate process managed by the Pharmaceutical Benefits Advisory Committee (PBAC).

This process can take months to years. A medication being approved overseas does not mean it is available — or even under review — in Australia. Patients should be cautious about assuming international approvals apply locally.

The Evolving Landscape of Weight Management Medication

Globally, the development of prescription weight management medications has accelerated in recent years. Several broad trends are relevant to the Australian market, even where specific products cannot be named on this site for regulatory reasons:

New drug classes — Medications based on incretin hormone pathways (such as GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists) have become a significant area of pharmaceutical development. These classes work through mechanisms related to appetite regulation, gastric emptying, and metabolic signalling.
Dual- and triple-action mechanisms — Research has expanded beyond single-receptor medications. Some newer formulations under development target two or three receptor pathways simultaneously, which may have different clinical profiles compared to earlier-generation treatments.
Oral formulations — Several medications that were previously only available as subcutaneous injections are now being developed or registered in oral tablet form, which may affect patient preferences and adherence.
Higher-dose formulations — Some existing medication classes are being evaluated at higher dosages than previously registered, with sponsors submitting new applications to the TGA for these formulations.
Combination approaches — There is growing interest in medications that combine weight management agents with treatments for related conditions such as type 2 diabetes, cardiovascular risk factors, or metabolic syndrome.

It is important to note that the existence of a new drug class or mechanism does not, in itself, indicate that any particular product is superior to existing options. Clinical outcomes depend on a wide range of factors, including individual patient characteristics, existing health conditions, concurrent medications, and adherence to the prescribed treatment plan.

What "New" Means in Regulatory Terms

When Australians hear that a "new" weight loss medication is available, it is worth understanding what that actually means in regulatory terms. There are several distinct stages, and a medication can be "new" in one sense while not yet accessible to patients:

TGA registration — The medication has been evaluated and registered on the ARTG. It can legally be prescribed and dispensed in Australia. However, it may not be affordable for many patients if it is not PBS-listed.
PBS listing — The medication has been recommended by the PBAC and listed on the PBS, making it available at a government-subsidised price. PBS listing often comes with specific criteria (e.g., BMI thresholds, prior treatment requirements) that determine who is eligible for the subsidy.
Supply availability — Even after registration and PBS listing, a medication may face supply constraints. Global demand, manufacturing capacity, and distribution logistics can all affect whether a registered medication is physically available at pharmacies.
Indication-specific approval — A medication may be TGA-registered for one indication (e.g., type 2 diabetes) but not yet approved for another (e.g., chronic weight management), even if it is used off-label for that purpose in other countries.

The distinction between these stages matters. A medication that is TGA-registered but not PBS-listed may cost patients several hundred dollars per month out of pocket. A medication that is PBS-listed but subject to supply shortages may not be available at your local pharmacy. Your prescribing doctor is the best source of current information about what is both approved and practically available for your specific situation.

How to Find Out What's Currently Available

Because the regulatory landscape changes frequently, this article cannot provide a definitive list of what is available at the time you are reading it. However, there are several reliable ways to check:

Search the ARTG — The Australian Register of Therapeutic Goods is publicly searchable at tga.gov.au. You can search by active ingredient, product name, or sponsor to see whether a specific medication is currently registered in Australia.
Check the PBS — The Pharmaceutical Benefits Scheme website (pbs.gov.au) lists all subsidised medications and their eligibility criteria. You can search by condition or active ingredient.
TGA medicine shortage reports — The TGA maintains a database of current medicine shortages at tga.gov.au/medicine-shortages. This can help you understand whether a registered medication is currently in supply.
Ask your doctor — Your prescribing doctor has access to current prescribing information and can advise on what is registered, available, and appropriate for your individual circumstances.
Ask your pharmacist — Pharmacists are well-placed to advise on current stock availability and can check whether a prescribed medication is in supply.

We strongly recommend against relying on social media, international news articles, or online forums for information about medication availability in Australia. Regulatory timelines and approvals differ significantly between countries.

What New Medications Mean for Patients

The introduction of new weight management medications into the Australian market is a positive development in the sense that it expands the range of options that prescribers can consider when developing a treatment plan. However, patients should understand that the core process of accessing these medications remains the same:

A medical assessment is required — No prescription weight loss medication should be taken without a thorough medical evaluation. This includes a review of your medical history, current medications, BMI, and any contraindications.
A valid prescription is necessary — In Australia, prescription weight loss medications are Schedule 4 (S4) substances, meaning they require a prescription from an authorised prescriber (typically a doctor or, in some cases, a nurse practitioner).
Ongoing monitoring is important — Weight management medications are not a one-off intervention. Regular follow-up appointments allow your prescriber to monitor your response, manage any side effects, and adjust the treatment plan as needed.
Lifestyle factors remain relevant — Prescription medication is typically most appropriate as part of a broader weight management plan that includes dietary considerations, physical activity, and behavioural support.

The availability of newer medications does not change these requirements. If anything, the expanding range of options makes individualised medical advice more important, not less, because your prescriber needs to consider which option — if any — is most appropriate for your specific clinical profile.

Important Considerations

Before seeking a prescription for any weight management medication — whether newly registered or long-established — there are several important factors to keep in mind:

"New" does not mean better for everyone — A recently registered medication may be an important option for some patients, but it is not automatically superior to existing treatments. Your doctor assesses suitability based on your individual health profile, not on how recently a medication was approved.
Long-term data may be limited — By definition, newer medications have shorter post-market surveillance histories. While TGA registration requires a robust evidence base, long-term outcomes data (five years, ten years, and beyond) accumulates over time. Your prescriber can discuss what is currently known and what remains under investigation.
Cost varies significantly — Not all registered medications are PBS-subsidised. Some newer treatments may only be available as private prescriptions, meaning the full cost is borne by the patient. This can range from tens to hundreds of dollars per month.
Supply may be inconsistent — Global demand for certain medication classes has led to intermittent supply issues in Australia and other markets. Your pharmacist can advise on current availability.
Off-label use carries additional considerations — If a medication is prescribed for a purpose not specifically included in its TGA-approved indications, this is known as "off-label" prescribing. While legal and sometimes clinically appropriate, it means the evidence base for that specific use may be different from the approved indication.

Frequently Asked Questions

Are there new weight loss medications available in Australia in 2026?

The TGA continues to evaluate and register new medications, including those in the weight management category. The regulatory landscape is evolving, and new products may enter the market at various points throughout the year. For the most current information, search the ARTG at tga.gov.au or speak with your doctor.

How do I know if a new medication is right for me?

Only an authorised prescriber — such as a doctor — can assess whether a particular medication is appropriate for your individual circumstances. This assessment takes into account your medical history, current health conditions, existing medications, BMI, and treatment goals. There is no substitute for an individualised medical consultation.

Can I buy new weight loss medications online in Australia?

Prescription weight loss medications can only be legally obtained with a valid prescription from an authorised prescriber. Some telehealth services, including Burst Health, facilitate online medical consultations where a doctor can assess your suitability and, if clinically appropriate, issue a prescription. The medication is then dispensed by a registered pharmacy. You should never purchase prescription medications from unregulated online sources.

What is the difference between TGA approval and PBS listing?

TGA registration means a medication has been assessed and approved for use in Australia based on its quality, safety, and efficacy. PBS listing means the government subsidises the cost of the medication for eligible patients, making it more affordable. A medication can be TGA-registered without being PBS-listed, in which case patients pay the full cost as a private prescription.

Why can't this article name specific medications?

Australian advertising regulations, enforced by the TGA, restrict the promotion of prescription medications to consumers. Telehealth services such as Burst Health are not permitted to name specific prescription products in consumer-facing content. This is a legal requirement designed to ensure that treatment decisions are made in clinical consultations rather than influenced by advertising. Your prescribing doctor can discuss specific medication options with you during your consultation.

Support Your Weight Management Journey with Burst Health

If you are considering prescription weight management medication — whether newly available or established — the first step is a medical assessment. Burst Health provides online consultations with Australian-registered doctors who can evaluate your suitability, discuss available treatment options, and issue a prescription if clinically appropriate.

Our process is straightforward: complete a health questionnaire, have your information reviewed by a doctor, and — if a prescription is issued — receive your medication via discreet delivery from a registered Australian pharmacy. All consultations are confidential, and our clinical team is available to support you throughout your treatment.

Start your online weight loss consultation today →